Korean J Gastroenterol.  2014 Jan;63(1):3-10. 10.4166/kjg.2014.63.1.3.

Chemoprevention of Colorectal Cancer in Inflammatory Bowel Disease

Affiliations
  • 1Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea. jh2002@dau.ac.kr

Abstract

The risk of developing colorectal cancer is increased in patients with inflammatory bowel disease. Surveillance colonoscopy has not been shown to prolong survival and rates of interval cancer are reported to be high. Continuing colonic inflammation has been shown to be important in the development of colorectal cancer and therefore anti-inflammatory agents such as the 5-aminosalicylates and immunomodulators have been considered as potential chemopreventive agents. This review focuses on various chemopreventive agents that have been clearly shown to reduce the risk of colorectal adenoma and cancer in the patients with inflammatory bowel disease.

Keyword

Chemoprevention; Inflammatory bowel diseases; Colorectal neoplasms
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr